Conference Organised by the Eurasian Association of Therapists

«Innovations in internal medicine»

Under the auspices of the Ministry of Health of the Russian Federation


Participation is free

25 March 2022


About the conference

Principal directions: (Key trends)

  • Scientific breakthrough in cardiology amid the COVID-19 pandemic: groundbreaking research findings in 2020-2021 and 2022.
  • Effects of sodium glucose cotransporter (SGLT2) inhibitors on risk of death and rate of hospitalization in patients with chronic heart failure in the EMPA-REG OUTCOME study.
  • The use of ARNI in the treatment of patients with arterial hypertension and chronic heart failure in the PARADIGM-HF study.
  • Effects of combined lipid-lowering therapy (statin + ezetimibe or statin + fenofibrate) in studies: ENHANCE, I-ROSETTE, SAFARI.
  • The use of anticoagulants in the post-COVID period (studies by MICHELLE and EINSTEIN-Jr).
  • Treatment algorithms for chronic kidney disease – current research, practical recommendations for day-to-day practices.
  • Issues of prescribing new medications in the treatment of arterial hypertension: identification of indications, dose selection and therapy regimen correction.
  • Selecting basic combined lipid-lowering treatment – latest research results, new opportunities.
  • Use of hormonal and targeted therapy for COVID-19.
  • New dosage forms in therapy for type II diabetes mellitus.
  • Vaccination in 2022: new steps to enhance the efficiency of the population immunization.
  • Laboratory diagnostics in the post-COVID period – tools and points of application.

During the conference



In terms of the symposia we’ll plunge into new studies, new indications and new molecules. We’ll discuss how the latest developments that have appeared in medicine over the last 12 months may affect and change clinical medicine in the near future.



Practical component of the Conference that will help integrate new clinical experience into everyday practice. Direct communication with the speakers, clinical case studies, discussions and many other issues.
  • Hall №1

  • Hall №2

  • Hall №3

Opening of the Conference
Master class «COVID-19: do all questions have an answer?»

G.E. Gendlin, N.G. Poteshkina, A.V. Melekhov

Heart failure in COVID-19: do all questions have an answer?
N.G. Poteshkina
Patients with COVID-19 at the hospital and post-hospital period – do they need a heart check-up?
G.E. Gendlin
Post-Covid syndrome
A.V. Melekhov
Special Session (60 minutes) «New molecules and new approaches in CHF therapy»

G.P. Arutyunov

Symposium «COVID-19: The accumulated experience»

A.G. Arutyunov

Two years of COVID-19, the experience of 7 countries
E.I. Tarlovskaya
Omicron: The differences in the clinical picture. Does the risk remain?
A.G. Arutyunov
Targeted therapy in the treatment of COVID-19 – data for 2022
S.N. Avdeev
Monoclonal antibodies in the treatment of COVID-19
D.S. Fomina
Symposium «Post-COVID: long-term changes»

A.G. Arutyunov

Management strategies for patients with hypertension during the pandemic
O.D. Ostroumova
A patient after COVID-19 as a new risk category
A.G. Arutyunov
Antibiotic-associated colitis in Post-COVID
N.V. Bakulina, O.I. Solovieva
Rehabilitation after COVID-19. Experience of the Republic of Armenia
Lamara Manukyan
Wrap up of the Conference
Broadcast in Hall №1
Opening of the Conference
Satellite Symposium «Innovations in intensification: LDL-C control in Russian realities»

(sponsored by Sanofi)

M.V. Ezhov

Dyslipidemia 2022: key trends and innovative solutions
M.V. Ezhov
The role of general practitioner in lipid storage disease management in patients with high and very high CV risk
A.G. Arutyunov
New opportunities in lipid-lowering therapy intensification
Yu.A. Karpov
Opportunities in the routing organization and effective treatment in patients with ACS: the place of PCSK9i
A.Yu. Lebedeva
Satellite Symposium «The renaissance of the future: Long-awaited reality in treatment of CKD patients»

(sponsored by AstraZeneca)

A.G. Arutyunov

A change navigator, focus on early diagnosis of patients with CKD
T.V. Adasheva
The birth of the future: DAPA-CKD as revolution of ideas in CKD patients management
O.Yu. Sukhareva
Caring for the heart: Findings from the DAPA-CKD trial in patients with cardiovascular diseases
S.V. Villevalde
Satellite Symposium «Type 2 diabetes and heart failure. How to sail between Scylla and Charybdis without a loss?»

(sponsored by Boehringer Ingelheim)

G.P. Arutyunov

Heart failure with reduced ejection fraction – the importance of nephroprotective therapy
M. Batyushin
When do we start therapy for heart failure with SGLT2 inhibitors: inpatient or outpatient?
G. Arutyunov
Type 2 diabetes and heart failure. How to sail between Scylla and Charybdis without a loss?
Yu.Sh. Khalimov
Practical aspects of iSGLT2 use when administered without type 2 diabetes mellitus
I.В. Zhirov
Symposium «From atherosclerosis to CHF: what’s new in 2022»

O.N. Dzhioeva

A patient with thrombosis: diversity of the problem and unity of solution
O.N. Dzhioeva
Oral GLP-1 receptor agonists: new perspectives
Sarantis LIvadas (Athens)
Therapy to prevent deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients with CHF (congestive heart failure) – new steps in 2022
Akhmetzhan Sugraliev
Broadcast in Hall №1
Wrap up of the Conference
Broadcast in Hall №1
Opening of the Conference
Broadcast in Halls №1 and №2
No broadcast
No broadcast
No broadcast
Broadcast in Hall №1
Wrap up of the Conference


The Congress will be attended by leading experts, scientists and physicians specialising in various areas of medicine from 6 countries: Russia, Slovenia, Serbia, Croatia, Romania, France.

If you have any questions about
cooperation, please contact us at the
following address

About the Association

The Eurasian Association of Internal Medicine is an independent association that provides an opportunity for its members to share experience and discuss crucial problems of evidence-based medicine and clinical practice.

Among the Association’s main goals is to disseminate information about ground-breaking research in the field of internal medicine.

The Association holds free events for medical specialists letting them earn CME credit points.

Medical specialists may become members of the EAT’s expert community and get access to
more materials on the Association’s website

Go to the website


This event is organized for medical professionals: practicing physicians, residents, medical students.

Participation is free.

The broadcast can be viewed on this website. It will be available on the day of the conference – March 25, 2022.

Past Events

Watch recordings of past events of the Eurasian Association of Internal Medicine

«Comorbid patients in the pandemic era» 2021


«Eurasian Association of Internal Medicine» 2021